Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: Psychometric analysis of the obsessive compulsive drug use scale

International Journal of Methods in Psychiatric Research

Volumn 21, Issue 4, 2012, Pages 286-300

  Dekker, Nienke ^a   Koeter, Maarten ^a,b   Van Den Brink, Wim ^a,b   Kahn, René S ^c   Linszen, Don H ^a   Vanos, Jim ^d   Wiersma, Durk ^e   Bruggeman, Richard ^e   Cahn, Wiepke ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cannabis; Craving; Factor analysis; Reliability; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; COHORT ANALYSIS; COMPULSION; DRUG SEEKING BEHAVIOR; FEMALE; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; PSYCHOSIS; REPRODUCIBILITY; SIBLING;

ADOLESCENT; ADULT; COHORT STUDIES; COMPULSIVE BEHAVIOR; DRUG-SEEKING BEHAVIOR; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SIBLINGS; YOUNG ADULT;

EID: 84870486940     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.1362     Document Type: Article

References (53)

1. Akerele E., Levin F.R. (2007) Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. The American Journal on Addictions, 16(4), 260-268, DOI: 10.1080/10550490701389658.
2. American Psychiatric Association (APA). (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM IV, Washington, DC, APA.
3. Andreasen N.C., Flaum M., Arndt S. (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry, 49(8), 615-623.
4. Anton R.F., Moak D.H., Latham P.K. (1996) The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Archives of General Psychiatry, 53(3), 225-231.
5. Arsenault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. The British Medical Journal, 325(7374), 1212-1213.
6. Barnes T.R., Mutsatsa S.H., Hutton S.B., Watt H.C., Joyce E.M. (2006) Comorbid substance use and age at onset of schizophrenia. The British Journal of Psychiatry, 188, 237-242, DOI: 10.1192/bjp.bp.104.007237.
7. Cantwell R., Brewin J., Glazebrook C., Dalkin T., Fox R., Medley I., Harrison, G. (1999) Prevalence of substance misuse in first-episode psychosis. The British Journal of Psychiatry, 174, 150-153.
8. Cotto J.H., Davis E., Dowling G.J., Elcano J.C., Staton A.B., Weiss S.R. (2010) Gender effects on drugs use, abuse, and dependence: a special analysis of results from the national survey on drug use and health. Gender Medicine, 7(5), 402-413, DOI: 10.1016/j.genm.2010.09.004.
9. Dekker N., Linszen D.H., De Haan L. (2009) Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders. Psychopathology, 42(6), 350-360, DOI: 10.1159/000236906.
10. Dekker N., Smeerdijk A.M., Wiers R.W., Duits J.H., Van Gelder G., Houben K., Schippers G., Linszen D.H., De Haan L. (2010) Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Psychological Medicine, 40(8), 1325-1336, DOI: 10.1017/S0033291709991814.
11. Doherty K., Kinnunen T., Militello F.S., Garvey A.J. (1995) Urges to smoke during the first month of abstinence: relationship to relapse and predictors. Psychopharmacology, 119(2), 171-178.
12. Ferdinand R.F., Sondeeijker F., Van der Ende J., Selten J.P., Huizink A., Verhulst F.C. (2005) Cannabis use predicts future psychotic symptoms, and vice versa. Addiction, 100(5), 612-618, DOI: 10.1111/j.1360-0443.2005.01070.x.
13. Fergusson D.M., Horwood L.J., Ridder E.M. (2005) Tests of causal linkages between cannabis use and psychotic symptoms. Addiction, 100(3), 354-366, DOI: 10.1111/j.1360-0443.2005.01001.x.
14. Foti D.J., Kotov R., Guey L.T., Bromet E.J. (2010) Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. The American Journal of Psychiatry, 167(8), 987-993, DOI 10.1176/appi.ajp.2010.09020189.
15. Franken I.H. (2003) Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27(4), 563-579, DOI: 10.1016/S0278-5846(03)00081-2.
16. Franken I.H., Hendriks V.M., Van den Brink W. (2002) Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addictive Behaviors, 27(5), 675-685.
17. Franken I.H., Kroon L.Y., Hendriks V.M. (2000a) Influence of individual differences in craving and obsessive cocaine thoughts on attentional processes in cocaine abuse patients. Addictive Behaviors, 25(1), 99-102.
18. Franken I.H., Kroon L.Y., Wiers R.W., Jansen A. (2000b) Selective cognitive processing of drug cues in heroin dependence. The Journal of Psychopharmacology, 14(4), 395-400.
19. Gonzalez-Pinto A., Vega P., Ibanez B., Mosquera F., Barbeito S., Gutierrez M., Ruiz de Azua S., Ruiz I., Vieta E. (2008) Impact of cannabis and other drugs on age at onset of psychosis. The Journal of Clinical Psychiatry, 69(8), 1210-1216.
20. Gottesman I. (1991) Schizophrenia Genesis: The Origins of Madness, New York, Freeman.
21. Green A. (2005) Schizophrenia and comorbid substance use disorder: effects of antipsychotics. The Journal of Clinical Psychiatry, 66(suppl 6), 21-26.
22. GROUP investigators. (2011) Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control [1] pairs. Archives of General Psychiatry, 68(2), 138-147, DOI: 10.1001/archgenpsychiatry.2010.132.
23. Hall W., Degenhardt L. (2000) Cannabis use and psychosis: a review of clinical and epidemiological evidence. The Australian and New Zealand Journal of Psychiatry, 34(1), 26-34.
24. Hambrecht M., Häfner H. (1996) Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40(11), 1155-1163.
25. Hartz D.T., Frederick-Osborne S.L., Galloway G.P. (2001) Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug and Alcohol Dependence, 63(3), 269-276.
26. Heishman S.J., Evans R.J., Singleton E.G., Levin K.H., Copersino M.L., Gorelick D.A. (2009) Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug and Alcohol Dependence, 102(1-3), 35-40, DOI: 10.1016/j.drugalcdep.2008.12.010.
27. Heishman S.J., Singleton E.G., Liguori A. (2001) Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction, 96(7), 1023-1034, DOI: 10.1080/09652140120053084.
28. Henquet C., Krabbendam L., Spauwen J, Kaplan C., Lieb R., Wittchen H.U., van Os J. (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. The British Medical Journal, 330(7481), 11-15, DOI: 10.1136/bmj.38267.664086.63.
29. Kay S.R., Fiszbein A., Opler L.A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276.
30. Kiers H.A.L. (1990) A Program for Simultaneous Component Analysis, Groningen, IEC Programma.
31. Korver N., Quee P.J., Boos H., Simons C., GROUP authors. (2012) Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment, assessment methods and validity of diagnostic categories. International Journal of Methods in Psychiatry Research, DOI: 10.1002/mpr.1352.
32. Linszen D.H., Dingemans P.M., Lenior M.E. (1994) Cannabis abuse and the course of recent onset schizophrenic disorders. Archives of General Psychiatry, 51(4), 273-279.
33. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. (1992) The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9(3), 199-213.
34. Millsap R.E., Meredith W. (1988) Component analysis in cross-sectional and longitudinal data. Psychometrika, 53(1), 123-134.
35. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet, 370(9584), 319-328, DOI: 10.1016/S0140-6736(07)61162-3.
36. Musshoff F., Madea B. (2006) Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Therapeutic Drug Monitoring, 28(2), 155-163, DOI: 10.1097/01.ftd.0000197091.07807.22.
37. Potvin S., Stip E., Lipp O., Elie R., Mancini-Marië A., Demers M.F., Roy M.A., Bouchard R.H., Gendron A. (2006) Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Current Medical Research and Opinion, 22(7), 1277-1285, DOI: 10.1185/030079906X112561.
38. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264(19), 2511-2518.
39. Robbins S.J., Ehrman R.N. (1998) Cocaine use is associated with increased craving in outpatient cocaine abusers. Experimental and Clinical Psychopharmacology, 6(2), 217-224.
40. Roberts J.S., Anton R.F., Latham P.K., Moak D.H. (1999) Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcoholism, Clinical and Experimental Research, 23(9), 1484-1491.
41. Robinson T.E., Berridge K.C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research. Brain Research Reviews, 18(3), 247-291.
42. Sayette M.A., Shiffman S., Tiffany S.T., Niaura R.S., Martin C.S., Shadel W.G. (2000) The measurement of drug craving. Addiction, 95(Suppl. 2), S189-S210.
43. Schippers G.M., De Jong C.A.J., Lehert Ph., Potgieter A., Deckers F., Casselman J., Geerlings P.J. (1997) The obsessive compulsive drinking scale: translation into Dutch and possible modifications. European Addiction Research, 3, 116-122.
44. Singleton E.G., Trotman A.J., Zavahir M., Taylor R.C., Heishman S.J. (2002) Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts. Experimental and Clinical Psychopharmacology, 10(1), 47-53.
45. Smith M.J., Barch D.M., Wolf T.J., Mamah D., Csernansky J.G. (2008) Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research, 106(9), 294-299, DOI: 10.1016/j.schres.2008.07.015.
46. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., Van Os J. (2004) Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction, 99(3), 1333-1341, DOI: 10.1111/j.1360-0443.2004.00806.x.
47. Van Nimwegen L.J., De Haan L., Van Beveren N.J., van der Helm M., Van den Brink W., Linszen D. (2008) Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. The Canadian Journal of Psychiatry, 53(6), 400-405.
48. Van Os J., Bak M., Hanssen M., Bijl R.V., De Graaf R., Verdoux H. (2002) Cannabis use and psychosis: a longitudinal population-based study. The American Journal of Epidemiology, 156(4), 319-327.
49. Van Winkel R., GROUP Investigators. (2011) Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Archives of General Psychiatry, 68(2), 148-157, DOI: 10.1001/archgenpsychiatry.2010.152.
50. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., Jablenski A., Regier D., Sartorius N. (1990) SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry, 47(6), 589-593.
51. World Health Organisation (WHO). (1994) Composite International Diagnostic Interview: Researchers' Manual, Geneva, WHO.
52. World Health Organisation (WHO). (2008) WHO lexicon. WHO website. http://www.who.int/substance_abuse/terminology/who_lexicon/en/index.html.
53. Zammit S., Moore T.H., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. The British Journal of Psychiatry, 193(5), 357-363, DOI: 10.1192/bjp.bp.107.046375.